BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34518334)

  • 1. Charcot-Marie-Tooth disease type 2CC due to
    Pipis M; Cortese A; Polke JM; Poh R; Vandrovcova J; Laura M; Skorupinska M; Jacquier A; Juntas-Morales R; Latour P; Petiot P; Sole G; Fromes Y; Shah S; Blake J; Choi BO; Chung KW; Stojkovic T; Rossor AM; Reilly MM
    J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):48-56. PubMed ID: 34518334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charcot-Marie-Tooth disease type 2CC due to a frameshift mutation of the neurofilament heavy polypeptide gene in an Austrian family.
    Ikenberg E; Reilich P; Abicht A; Heller C; Schoser B; Walter MC
    Neuromuscul Disord; 2019 May; 29(5):392-397. PubMed ID: 30992180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Genome Linkage Analysis with Whole-Exome Sequencing Identifies a Novel Frameshift Variant in NEFH in a Chinese Family with Charcot-Marie-Tooth 2: A Novel Variant in NEFH for Charcot-Marie-Tooth 2.
    Bian X; Lin P; Li J; Long F; Duan R; Yuan Q; Li Y; Gao F; Gao S; Wei S; Li X; Sun W; Gong Y; Yan C; Liu Q
    Neurodegener Dis; 2018; 18(2-3):74-83. PubMed ID: 29587262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal Charcot-Marie-Tooth neuropathy concurrent with distal and proximal weakness by translational elongation of the 3' UTR in NEFH.
    Nam DE; Jung SC; Yoo DH; Choi SS; Seo SY; Kim GH; Kim SJ; Nam SH; Choi BO; Chung KW
    J Peripher Nerv Syst; 2017 Sep; 22(3):200-207. PubMed ID: 28544463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proximal weakness involvement in the first Italian case of Charcot-Marie-Tooth 2CC harboring a novel frameshift variant in NEFH.
    Aruta F; Severi D; Iovino A; Spina E; Barghigiani M; Ruggiero L; Iodice R; Santorelli FM; Manganelli F; Tozza S
    J Peripher Nerv Syst; 2021 Jun; 26(2):231-234. PubMed ID: 33987933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
    Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C
    Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An NEFH founder mutation causes broad phenotypic spectrum in multiple Japanese families.
    Ando M; Higuchi Y; Okamoto Y; Yuan J; Yoshimura A; Takei J; Taniguchi T; Hiramatsu Y; Sakiyama Y; Hashiguchi A; Matsuura E; Nakagawa H; Sonoda K; Yamashita T; Tamura A; Terasawa H; Mitsui J; Ishiura H; Tsuji S; Takashima H
    J Hum Genet; 2022 Jul; 67(7):399-403. PubMed ID: 35091664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense pathogenic variant in NEFH causing rare Charcot-Marie-Tooth neuropathy type 2CC.
    Yan J; Qiao L; Peng H; Liu A; Wu J; Huang J
    Neurol Sci; 2021 Feb; 42(2):757-763. PubMed ID: 32780247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.
    Berciano J; Peeters K; García A; López-Alburquerque T; Gallardo E; Hernández-Fabián A; Pelayo-Negro AL; De Vriendt E; Infante J; Jordanova A
    J Neurol; 2016 Feb; 263(2):361-369. PubMed ID: 26645395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptic amyloidogenic elements in mutant NEFH causing Charcot-Marie-Tooth 2 trigger aggresome formation and neuronal death.
    Jacquier A; Delorme C; Belotti E; Juntas-Morales R; Solé G; Dubourg O; Giroux M; Maurage CA; Castellani V; Rebelo A; Abrams A; Züchner S; Stojkovic T; Schaeffer L; Latour P
    Acta Neuropathol Commun; 2017 Jul; 5(1):55. PubMed ID: 28709447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A compound heterozygous mutation in HADHB gene causes an axonal Charcot-Marie-tooth disease.
    Hong YB; Lee JH; Park JM; Choi YR; Hyun YS; Yoon BR; Yoo JH; Koo H; Jung SC; Chung KW; Choi BO
    BMC Med Genet; 2013 Dec; 14():125. PubMed ID: 24314034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.
    Claeys KG; Züchner S; Kennerson M; Berciano J; Garcia A; Verhoeven K; Storey E; Merory JR; Bienfait HM; Lammens M; Nelis E; Baets J; De Vriendt E; Berneman ZN; De Veuster I; Vance JM; Nicholson G; Timmerman V; De Jonghe P
    Brain; 2009 Jul; 132(Pt 7):1741-52. PubMed ID: 19502294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P₂ phosphatase FIG4.
    Nicholson G; Lenk GM; Reddel SW; Grant AE; Towne CF; Ferguson CJ; Simpson E; Scheuerle A; Yasick M; Hoffman S; Blouin R; Brandt C; Coppola G; Biesecker LG; Batish SD; Meisler MH
    Brain; 2011 Jul; 134(Pt 7):1959-71. PubMed ID: 21705420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and clinical characteristics of
    Horga A; Laurà M; Jaunmuktane Z; Jerath NU; Gonzalez MA; Polke JM; Poh R; Blake JC; Liu YT; Wiethoff S; Bettencourt C; Lunn MP; Manji H; Hanna MG; Houlden H; Brandner S; Züchner S; Shy M; Reilly MM
    J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):575-585. PubMed ID: 28501821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
    Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
    Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features in two families with MARS-related Charcot-Marie-Tooth disease.
    Ma Z; Lv H; Zhang H; Wang H; Li J; Yu M; Zhu Y; Huang D; Meng L; Yuan Y
    Neuropathology; 2022 Dec; 42(6):505-511. PubMed ID: 35723632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
    Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
    Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton.
    Fabrizi GM; Cavallaro T; Angiari C; Cabrini I; Taioli F; Malerba G; Bertolasi L; Rizzuto N
    Brain; 2007 Feb; 130(Pt 2):394-403. PubMed ID: 17052987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.